Volatile anesthetics are a clinically important class of drugs whose mechanism of action is not understood. Besides the potential to rationally design safer and more effective anesthetics, elucidating anesthetic mechanisms should impact fundamental areas of neurobiology such as synaptic transmission, consciousness, and memory. Genetics is an essential tool for determining which molecular events are actually responsible for anesthetic-induced nervous system depression. The nematode Caenorhabditis elegans is a powerful genetic model that has a simple nervous system utilizing the same fundamental synaptic machinery as humans. We have found that an unusual mutation in the highly conserved gene coding for syntaxin renders C. elegans resistant to clinical concentrations of volatile anesthetics. We have also found that the anesthetic isoflurane binds to rat SNAP-25, one of the proteins that tightly interacts with syntaxin. Our proposed experiments are designed to explore this astonishing discovery by: 1) Identifying the region of mutant syntaxin necessary and sufficient to produce anesthetic resistance. 2) Identifying genes that function along with syntaxin to regulate anesthetic action and attempt to find mutants in SNAP-25 that are resistant to anesthetics 3) Determine the pathway and cells through which these genes act to mediate anesthetic effects 4) Determine whether anesthetics bind to SNAP-25 when in complex with syntaxin and define by mutagenesis the binding site for anesthetics on SNAP-25. The mechanism of action of volatile anesthetics that will be defined by the proposed work can be used to interpret and guide vertebrate experiments such as transgenic mice knockouts. The combination of invertebrate and vertebrate genetics and in vitro studies should finally allow us to reach our goal of understanding the mechanism of action of this clinically and scientifically important class of drugs.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Cole, Alison E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Saifee, Owais; Metz, Laura B; Nonet, Michael L et al. (2011) A gain-of-function mutation in adenylate cyclase confers isoflurane resistance in Caenorhabditis elegans. Anesthesiology 115:1162-71
Jia, Baosen; Crowder, C Michael (2008) Volatile anesthetic preconditioning present in the invertebrate Caenorhabditis elegans. Anesthesiology 108:426-33
Metz, Laura B; Dasgupta, Nupur; Liu, Christine et al. (2007) An evolutionarily conserved presynaptic protein is required for isoflurane sensitivity in Caenorhabditis elegans. Anesthesiology 107:971-82
Dasgupta, Nupur; Patel, Aditya M; Scott, Barbara A et al. (2007) Hypoxic preconditioning requires the apoptosis protein CED-4 in C. elegans. Curr Biol 17:1954-9
Wu, Xin-Sheng; Sun, Jian-Yuan; Evers, Alex S et al. (2004) Isoflurane inhibits transmitter release and the presynaptic action potential. Anesthesiology 100:663-70
van Swinderen, Bruno; Metz, Laura B; Shebester, Laynie D et al. (2002) A Caenorhabditis elegans pheromone antagonizes volatile anesthetic action through a go-coupled pathway. Genetics 161:109-19
van Swinderen, B; Metz, L B; Shebester, L D et al. (2001) Goalpha regulates volatile anesthetic action in Caenorhabditis elegans. Genetics 158:643-55